Celltrion receives US FDA approval of 300mg strength of Omlyclo, the first and only interchangeable biosimilar to Xolair: Incheon, South Korea Thursday, December 4, 2025, 11:00 Hr ...
U.S. Food and Drug Administration (FDA) has approved a new presentation of OMLYCLO® (omalizumab-igec), the first and only biosimilar designated as interchangeable with XOLAIR® (omalizumab), in a 300mg ...
11hon MSN
'Our only son' - Matthew Perry's parents want lengthy sentence for doctor who supplied ketamine
"Matthew's recovery counted on you saying NO," his father, John, and step-mother, Debbie, wrote in one of the victim impact ...
Omlyclo was originally approved in March 2025 in 2 single-dose prefilled syringe strengths: 75mg/0.5mL and 150mg/mL.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback